# A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Arthritis

> **NCT02727764** · PHASE1 · UNKNOWN · sponsor: **Arthrogen** · enrollment: 12 (estimated)

## Conditions studied

- Arthritis, Rheumatoid
- Osteo Arthritis

## Interventions

- **GENETIC:** ART-I02

## Key facts

- **NCT ID:** NCT02727764
- **Lead sponsor:** Arthrogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-20
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2018-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02727764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02727764, "A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Arthritis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02727764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*